Review



a375  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC a375
    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) <t>A375</t> and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.
    A375, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 5682 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375/product/ATCC
    Average 99 stars, based on 5682 article reviews
    a375 - by Bioz Stars, 2026-03
    99/100 stars

    Images

    1) Product Images from "STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation"

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2026.13828

    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) A375 and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.
    Figure Legend Snippet: STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) A375 and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.

    Techniques Used: Knockdown, Expressing, Western Blot, Cell Counting, Colony Assay, Small Interfering RNA, Negative Control

    STAT1 knockdown significantly promotes melanoma cell apoptosis and inhibits migration. (A and B) Apoptosis was assessed and quantified in A375 and RPMI-7951 cells following STAT1 knockdown using flow cytometry. (C) Transwell migration assays were conducted to evaluate cell migration following STAT1 knockdown. Magnification, ×200. (D) Quantification of migration capacity in A375 and RPMI-7951 cells following STAT1 knockdown. *P<0.05 vs. si-NC. STAT1, signal transducer and activator of transcription 1; si-STAT1, small interfering RNA targeting STAT1; si-NC, negative control small interfering RNA.
    Figure Legend Snippet: STAT1 knockdown significantly promotes melanoma cell apoptosis and inhibits migration. (A and B) Apoptosis was assessed and quantified in A375 and RPMI-7951 cells following STAT1 knockdown using flow cytometry. (C) Transwell migration assays were conducted to evaluate cell migration following STAT1 knockdown. Magnification, ×200. (D) Quantification of migration capacity in A375 and RPMI-7951 cells following STAT1 knockdown. *P<0.05 vs. si-NC. STAT1, signal transducer and activator of transcription 1; si-STAT1, small interfering RNA targeting STAT1; si-NC, negative control small interfering RNA.

    Techniques Used: Knockdown, Migration, Flow Cytometry, Small Interfering RNA, Negative Control

    STAT1 regulates TUBB4A expression at the transcription level. (A) STAT1 mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (B) TUBB4A mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (C) Specific fragments of the TUBB4A promoter region were cloned into the luciferase reporter plasmids upstream of the firefly luciferase gene. (D) Transcriptional activity of various TUBB4A promoter fragments was analyzed by luciferase reporter assay in 293T cells, with the −1,783 and −1,771 fragments exhibiting the highest activity. (E) STAT1 siRNA-mediated knockdown significantly reduced STAT1 mRNA levels in A375 cells. (F) STAT1 knockdown significantly reduced the luciferase activity of the −1,783 fragment of the TUBB4A promoter, but not the −1,771 fragment. (G) Chromatin immunoprecipitation assays were performed in A375 and RPMI-7951 cells targeting the −1,783 binding site in the TUBB4A promoter region. Quantitative PCR provided evidence of STAT1 binding to this region. Genomic DNA input was set to 100%. **P<0.01 vs. si-NC; ## P<0.01 vs. PGL3; && P<0.01 vs. IgG. STAT1, signal transducer and activator of transcription 1; siRNA, small interfering RNA; si-NC, negative control siRNA; si-STAT1, siRNA targeting STAT1; si-STAT1-1, siRNA targeting STAT1 sequence 1; si-STAT1-2, siRNA targeting STAT1 sequence 2; TUBB4A, tubulin β4A; PGL3, promoter-gluc luciferase 3; LUC, firefly luciferase gene.
    Figure Legend Snippet: STAT1 regulates TUBB4A expression at the transcription level. (A) STAT1 mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (B) TUBB4A mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (C) Specific fragments of the TUBB4A promoter region were cloned into the luciferase reporter plasmids upstream of the firefly luciferase gene. (D) Transcriptional activity of various TUBB4A promoter fragments was analyzed by luciferase reporter assay in 293T cells, with the −1,783 and −1,771 fragments exhibiting the highest activity. (E) STAT1 siRNA-mediated knockdown significantly reduced STAT1 mRNA levels in A375 cells. (F) STAT1 knockdown significantly reduced the luciferase activity of the −1,783 fragment of the TUBB4A promoter, but not the −1,771 fragment. (G) Chromatin immunoprecipitation assays were performed in A375 and RPMI-7951 cells targeting the −1,783 binding site in the TUBB4A promoter region. Quantitative PCR provided evidence of STAT1 binding to this region. Genomic DNA input was set to 100%. **P<0.01 vs. si-NC; ## P<0.01 vs. PGL3; && P<0.01 vs. IgG. STAT1, signal transducer and activator of transcription 1; siRNA, small interfering RNA; si-NC, negative control siRNA; si-STAT1, siRNA targeting STAT1; si-STAT1-1, siRNA targeting STAT1 sequence 1; si-STAT1-2, siRNA targeting STAT1 sequence 2; TUBB4A, tubulin β4A; PGL3, promoter-gluc luciferase 3; LUC, firefly luciferase gene.

    Techniques Used: Expressing, Knockdown, Transfection, Clone Assay, Luciferase, Activity Assay, Reporter Assay, Chromatin Immunoprecipitation, Binding Assay, Real-time Polymerase Chain Reaction, Small Interfering RNA, Negative Control, Sequencing

    TUBB4A overexpression mitigates the effects of STAT1 knockdown on cell viability and proliferation. TUBB4A mRNA levels were measured in (A) A375 and (B) RPMI-7951 cells following TUBB4A overexpression mediated by a lentiviral vector. (C) TUBB4A protein expression was analyzed after its overexpression. Combined STAT1 knockdown and TUBB4A overexpression transfections were performed, followed by a western blot analysis of TUBB4A protein levels in (D) A375 and (E) RPMI-7951 cells. Cell viability was assessed via Cell Counting Kit-8 assays following combined STAT1 knockdown and TUBB4A overexpression in (F) A375 and (G) RPMI-7951 cells. (H) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown and TUBB4A overexpression. (I) Quantification of colony formation assay results. **P<0.01 vs. Ov-NC; ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; STAT1, signal transducer and activator of transcription 1; si-NC, negative control small interfering RNA; si-STAT1, small interfering RNA targeting STAT1; Ov-NC, negative control lentiviral overexpression vector; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.
    Figure Legend Snippet: TUBB4A overexpression mitigates the effects of STAT1 knockdown on cell viability and proliferation. TUBB4A mRNA levels were measured in (A) A375 and (B) RPMI-7951 cells following TUBB4A overexpression mediated by a lentiviral vector. (C) TUBB4A protein expression was analyzed after its overexpression. Combined STAT1 knockdown and TUBB4A overexpression transfections were performed, followed by a western blot analysis of TUBB4A protein levels in (D) A375 and (E) RPMI-7951 cells. Cell viability was assessed via Cell Counting Kit-8 assays following combined STAT1 knockdown and TUBB4A overexpression in (F) A375 and (G) RPMI-7951 cells. (H) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown and TUBB4A overexpression. (I) Quantification of colony formation assay results. **P<0.01 vs. Ov-NC; ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; STAT1, signal transducer and activator of transcription 1; si-NC, negative control small interfering RNA; si-STAT1, small interfering RNA targeting STAT1; Ov-NC, negative control lentiviral overexpression vector; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Techniques Used: Over Expression, Knockdown, Plasmid Preparation, Expressing, Transfection, Western Blot, Cell Counting, Colony Assay, Negative Control, Small Interfering RNA

    TUBB4A overexpression reverses the effects of STAT1 knockdown on apoptosis, migration and tumor growth. (A-D) Apoptosis and migration were evaluated in A375 and RPMI-7951 cells following STAT1 knockdown and TUBB4A overexpression. Magnification, ×200. (E) Representative images of isolated xenograft tumors in mice. Tumor volumes were measured in nude mice injected subcutaneously with 2×10 6 A375 cells that had been subject to STAT1 knockdown and TUBB4A overexpression. (F) Quantification of mouse tumor volumes showed that STAT1 knockdown significantly suppressed tumor growth, whereas TUBB4A overexpression reversed this inhibitory effect. ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; si-NC, negative control small interfering RNA; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.
    Figure Legend Snippet: TUBB4A overexpression reverses the effects of STAT1 knockdown on apoptosis, migration and tumor growth. (A-D) Apoptosis and migration were evaluated in A375 and RPMI-7951 cells following STAT1 knockdown and TUBB4A overexpression. Magnification, ×200. (E) Representative images of isolated xenograft tumors in mice. Tumor volumes were measured in nude mice injected subcutaneously with 2×10 6 A375 cells that had been subject to STAT1 knockdown and TUBB4A overexpression. (F) Quantification of mouse tumor volumes showed that STAT1 knockdown significantly suppressed tumor growth, whereas TUBB4A overexpression reversed this inhibitory effect. ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; si-NC, negative control small interfering RNA; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Techniques Used: Over Expression, Knockdown, Migration, Isolation, Injection, Negative Control, Small Interfering RNA, Plasmid Preparation



    Similar Products

    a375  (ATCC)
    99
    ATCC a375
    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) <t>A375</t> and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.
    A375, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375/product/ATCC
    Average 99 stars, based on 1 article reviews
    a375 - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    97
    ATCC human melanoma cell line a375
    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) <t>A375</t> and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.
    Human Melanoma Cell Line A375, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human melanoma cell line a375/product/ATCC
    Average 97 stars, based on 1 article reviews
    human melanoma cell line a375 - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    99
    ATCC a375 atcc
    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) <t>A375</t> and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.
    A375 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375 atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    a375 atcc - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    95
    ATCC a375 ma2
    Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or <t>A375-MA2,</t> and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.
    A375 Ma2, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375 ma2/product/ATCC
    Average 95 stars, based on 1 article reviews
    a375 ma2 - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    a375p  (ATCC)
    95
    ATCC a375p
    Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines <t>A375P</t> or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.
    A375p, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375p/product/ATCC
    Average 95 stars, based on 1 article reviews
    a375p - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    ATCC a375 crl1619 melanoma cells
    (A, B, C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A), ROCK1, and ROCK2 are observed, corresponding to siRNA treatment compared with non-silencing control (NSC) in (A) A549, (B) H460, and (C) <t>A375</t> cells (as an experimental control). Tubulin was used as a loading control. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel, percentage of invaded cells compared with NSC cells at (D) 24 h for A549, n = >4, (E) 48 h for H460, n = 6, and (F) 16 h for A375 cells, n = 3 (as an experimental control). (G, H) A549 wound healing assay. (G) Time course, percentage wound closure at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (H) Percentage wound closure at 24 h compared with wound at 0 h, n = 5. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant.
    A375 Crl1619 Melanoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a375 crl1619 melanoma cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    a375 crl1619 melanoma cells - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    Image Search Results


    STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) A375 and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.

    Journal: Molecular Medicine Reports

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    doi: 10.3892/mmr.2026.13828

    Figure Lengend Snippet: STAT1 knockdown significantly reduces melanoma cell viability and proliferation. STAT1 mRNA expression was analyzed in (A) A375 and (B) RPMI-7951 melanoma cells post-STAT1 knockdown using siRNA. (C) Western blotting was used to assess STAT1 protein levels in melanoma cell lines following siRNA-mediated knockdown. Cell viability was evaluated after STAT1 knockdown in (D) A375 and (E) RPMI-7951 cells using Cell Counting Kit-8 assays. (F) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown. (G) Quantification of colony formation assay results. **P<0.01 vs. si-NC group. siRNA, small interfering RNA; STAT1, signal transducer and activator of transcription 1; si-STAT1, siRNA targeting STAT1; si-NC, negative control siRNA.

    Article Snippet: The melanoma cell lines A2058 (cat. no. CRL-3601), SK-MEL-1 (cat. no. HTB-67), A375 (cat. no. CRL-1619) and RPMI-7951 (cat. no. HTB-66), as well as normal human epidermal melanocytes (HEM; cat. no. PCS-200-013) and 293T cells (cat. no. CRL-3216) were obtained from American Type Culture Collection.

    Techniques: Knockdown, Expressing, Western Blot, Cell Counting, Colony Assay, Small Interfering RNA, Negative Control

    STAT1 knockdown significantly promotes melanoma cell apoptosis and inhibits migration. (A and B) Apoptosis was assessed and quantified in A375 and RPMI-7951 cells following STAT1 knockdown using flow cytometry. (C) Transwell migration assays were conducted to evaluate cell migration following STAT1 knockdown. Magnification, ×200. (D) Quantification of migration capacity in A375 and RPMI-7951 cells following STAT1 knockdown. *P<0.05 vs. si-NC. STAT1, signal transducer and activator of transcription 1; si-STAT1, small interfering RNA targeting STAT1; si-NC, negative control small interfering RNA.

    Journal: Molecular Medicine Reports

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    doi: 10.3892/mmr.2026.13828

    Figure Lengend Snippet: STAT1 knockdown significantly promotes melanoma cell apoptosis and inhibits migration. (A and B) Apoptosis was assessed and quantified in A375 and RPMI-7951 cells following STAT1 knockdown using flow cytometry. (C) Transwell migration assays were conducted to evaluate cell migration following STAT1 knockdown. Magnification, ×200. (D) Quantification of migration capacity in A375 and RPMI-7951 cells following STAT1 knockdown. *P<0.05 vs. si-NC. STAT1, signal transducer and activator of transcription 1; si-STAT1, small interfering RNA targeting STAT1; si-NC, negative control small interfering RNA.

    Article Snippet: The melanoma cell lines A2058 (cat. no. CRL-3601), SK-MEL-1 (cat. no. HTB-67), A375 (cat. no. CRL-1619) and RPMI-7951 (cat. no. HTB-66), as well as normal human epidermal melanocytes (HEM; cat. no. PCS-200-013) and 293T cells (cat. no. CRL-3216) were obtained from American Type Culture Collection.

    Techniques: Knockdown, Migration, Flow Cytometry, Small Interfering RNA, Negative Control

    STAT1 regulates TUBB4A expression at the transcription level. (A) STAT1 mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (B) TUBB4A mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (C) Specific fragments of the TUBB4A promoter region were cloned into the luciferase reporter plasmids upstream of the firefly luciferase gene. (D) Transcriptional activity of various TUBB4A promoter fragments was analyzed by luciferase reporter assay in 293T cells, with the −1,783 and −1,771 fragments exhibiting the highest activity. (E) STAT1 siRNA-mediated knockdown significantly reduced STAT1 mRNA levels in A375 cells. (F) STAT1 knockdown significantly reduced the luciferase activity of the −1,783 fragment of the TUBB4A promoter, but not the −1,771 fragment. (G) Chromatin immunoprecipitation assays were performed in A375 and RPMI-7951 cells targeting the −1,783 binding site in the TUBB4A promoter region. Quantitative PCR provided evidence of STAT1 binding to this region. Genomic DNA input was set to 100%. **P<0.01 vs. si-NC; ## P<0.01 vs. PGL3; && P<0.01 vs. IgG. STAT1, signal transducer and activator of transcription 1; siRNA, small interfering RNA; si-NC, negative control siRNA; si-STAT1, siRNA targeting STAT1; si-STAT1-1, siRNA targeting STAT1 sequence 1; si-STAT1-2, siRNA targeting STAT1 sequence 2; TUBB4A, tubulin β4A; PGL3, promoter-gluc luciferase 3; LUC, firefly luciferase gene.

    Journal: Molecular Medicine Reports

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    doi: 10.3892/mmr.2026.13828

    Figure Lengend Snippet: STAT1 regulates TUBB4A expression at the transcription level. (A) STAT1 mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (B) TUBB4A mRNA levels were measured in A375 and RPMI-7951 cells after STAT1 knockdown via transfection with different siRNA sequences. (C) Specific fragments of the TUBB4A promoter region were cloned into the luciferase reporter plasmids upstream of the firefly luciferase gene. (D) Transcriptional activity of various TUBB4A promoter fragments was analyzed by luciferase reporter assay in 293T cells, with the −1,783 and −1,771 fragments exhibiting the highest activity. (E) STAT1 siRNA-mediated knockdown significantly reduced STAT1 mRNA levels in A375 cells. (F) STAT1 knockdown significantly reduced the luciferase activity of the −1,783 fragment of the TUBB4A promoter, but not the −1,771 fragment. (G) Chromatin immunoprecipitation assays were performed in A375 and RPMI-7951 cells targeting the −1,783 binding site in the TUBB4A promoter region. Quantitative PCR provided evidence of STAT1 binding to this region. Genomic DNA input was set to 100%. **P<0.01 vs. si-NC; ## P<0.01 vs. PGL3; && P<0.01 vs. IgG. STAT1, signal transducer and activator of transcription 1; siRNA, small interfering RNA; si-NC, negative control siRNA; si-STAT1, siRNA targeting STAT1; si-STAT1-1, siRNA targeting STAT1 sequence 1; si-STAT1-2, siRNA targeting STAT1 sequence 2; TUBB4A, tubulin β4A; PGL3, promoter-gluc luciferase 3; LUC, firefly luciferase gene.

    Article Snippet: The melanoma cell lines A2058 (cat. no. CRL-3601), SK-MEL-1 (cat. no. HTB-67), A375 (cat. no. CRL-1619) and RPMI-7951 (cat. no. HTB-66), as well as normal human epidermal melanocytes (HEM; cat. no. PCS-200-013) and 293T cells (cat. no. CRL-3216) were obtained from American Type Culture Collection.

    Techniques: Expressing, Knockdown, Transfection, Clone Assay, Luciferase, Activity Assay, Reporter Assay, Chromatin Immunoprecipitation, Binding Assay, Real-time Polymerase Chain Reaction, Small Interfering RNA, Negative Control, Sequencing

    TUBB4A overexpression mitigates the effects of STAT1 knockdown on cell viability and proliferation. TUBB4A mRNA levels were measured in (A) A375 and (B) RPMI-7951 cells following TUBB4A overexpression mediated by a lentiviral vector. (C) TUBB4A protein expression was analyzed after its overexpression. Combined STAT1 knockdown and TUBB4A overexpression transfections were performed, followed by a western blot analysis of TUBB4A protein levels in (D) A375 and (E) RPMI-7951 cells. Cell viability was assessed via Cell Counting Kit-8 assays following combined STAT1 knockdown and TUBB4A overexpression in (F) A375 and (G) RPMI-7951 cells. (H) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown and TUBB4A overexpression. (I) Quantification of colony formation assay results. **P<0.01 vs. Ov-NC; ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; STAT1, signal transducer and activator of transcription 1; si-NC, negative control small interfering RNA; si-STAT1, small interfering RNA targeting STAT1; Ov-NC, negative control lentiviral overexpression vector; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Journal: Molecular Medicine Reports

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    doi: 10.3892/mmr.2026.13828

    Figure Lengend Snippet: TUBB4A overexpression mitigates the effects of STAT1 knockdown on cell viability and proliferation. TUBB4A mRNA levels were measured in (A) A375 and (B) RPMI-7951 cells following TUBB4A overexpression mediated by a lentiviral vector. (C) TUBB4A protein expression was analyzed after its overexpression. Combined STAT1 knockdown and TUBB4A overexpression transfections were performed, followed by a western blot analysis of TUBB4A protein levels in (D) A375 and (E) RPMI-7951 cells. Cell viability was assessed via Cell Counting Kit-8 assays following combined STAT1 knockdown and TUBB4A overexpression in (F) A375 and (G) RPMI-7951 cells. (H) Colony formation assays were performed to assess the proliferative capacity of cells after STAT1 knockdown and TUBB4A overexpression. (I) Quantification of colony formation assay results. **P<0.01 vs. Ov-NC; ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; STAT1, signal transducer and activator of transcription 1; si-NC, negative control small interfering RNA; si-STAT1, small interfering RNA targeting STAT1; Ov-NC, negative control lentiviral overexpression vector; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Article Snippet: The melanoma cell lines A2058 (cat. no. CRL-3601), SK-MEL-1 (cat. no. HTB-67), A375 (cat. no. CRL-1619) and RPMI-7951 (cat. no. HTB-66), as well as normal human epidermal melanocytes (HEM; cat. no. PCS-200-013) and 293T cells (cat. no. CRL-3216) were obtained from American Type Culture Collection.

    Techniques: Over Expression, Knockdown, Plasmid Preparation, Expressing, Transfection, Western Blot, Cell Counting, Colony Assay, Negative Control, Small Interfering RNA

    TUBB4A overexpression reverses the effects of STAT1 knockdown on apoptosis, migration and tumor growth. (A-D) Apoptosis and migration were evaluated in A375 and RPMI-7951 cells following STAT1 knockdown and TUBB4A overexpression. Magnification, ×200. (E) Representative images of isolated xenograft tumors in mice. Tumor volumes were measured in nude mice injected subcutaneously with 2×10 6 A375 cells that had been subject to STAT1 knockdown and TUBB4A overexpression. (F) Quantification of mouse tumor volumes showed that STAT1 knockdown significantly suppressed tumor growth, whereas TUBB4A overexpression reversed this inhibitory effect. ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; si-NC, negative control small interfering RNA; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Journal: Molecular Medicine Reports

    Article Title: STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation

    doi: 10.3892/mmr.2026.13828

    Figure Lengend Snippet: TUBB4A overexpression reverses the effects of STAT1 knockdown on apoptosis, migration and tumor growth. (A-D) Apoptosis and migration were evaluated in A375 and RPMI-7951 cells following STAT1 knockdown and TUBB4A overexpression. Magnification, ×200. (E) Representative images of isolated xenograft tumors in mice. Tumor volumes were measured in nude mice injected subcutaneously with 2×10 6 A375 cells that had been subject to STAT1 knockdown and TUBB4A overexpression. (F) Quantification of mouse tumor volumes showed that STAT1 knockdown significantly suppressed tumor growth, whereas TUBB4A overexpression reversed this inhibitory effect. ## P<0.01 vs. si-STAT1. TUBB4A, tubulin β4A; si-NC, negative control small interfering RNA; Ov-TUBB4A, lentiviral vector for TUBB4A overexpression.

    Article Snippet: The melanoma cell lines A2058 (cat. no. CRL-3601), SK-MEL-1 (cat. no. HTB-67), A375 (cat. no. CRL-1619) and RPMI-7951 (cat. no. HTB-66), as well as normal human epidermal melanocytes (HEM; cat. no. PCS-200-013) and 293T cells (cat. no. CRL-3216) were obtained from American Type Culture Collection.

    Techniques: Over Expression, Knockdown, Migration, Isolation, Injection, Negative Control, Small Interfering RNA, Plasmid Preparation

    Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.

    Journal: The Journal of Biological Chemistry

    Article Title: Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling

    doi: 10.1016/j.jbc.2026.111193

    Figure Lengend Snippet: Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.

    Article Snippet: A375P (Research Resource Identifier [RRID]: CVCL_6233), A375-MA2 (RRID: CVCL_X495), MDA-MB-468 (RRID: CVCL_0419), 786-O (RRID: CVCL_1051), SVEC4–10 (RRID: CVCL_4393), HUVEC (RRID: CVCL_9Q53), and BJ Fibroblast (RRID: CVCL_3653) cell lines were purchased from American Type Culture Collection.

    Techniques: Incubation, Control, Inverted Microscopy, Derivative Assay

    Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.

    Journal: The Journal of Biological Chemistry

    Article Title: Large extracellular vesicles regulate endothelial angiogenic potential via paracrine and autocrine signaling

    doi: 10.1016/j.jbc.2026.111193

    Figure Lengend Snippet: Melanoma L-EVs increase endothelial tube formation, distinct from sEVs. A , SVEC4–10 endothelial cells were incubated with no-treatment 1X PBS control, VEGF (20 ng/ml), or LOX L-EVs or sEVs, as described in the section. Cells were allowed to form tubes, and networks were imaged on an inverted microscope after 5 h. B , resulting tube networks were analyzed for the number of segments using Fiji and normalized to respective no-treatment controls among replicates. C and D , endothelial cells were incubated with L-EVs or sEVs derived from paired primary and metastatic cell lines A375P or A375-MA2, and the number of segments was quantified using Fiji. Data are presented as means ± SD. The p values were obtained by one-way ANOVA with Dunnett’s correction (ns, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) from at least three independent experiments. L-EV, large extracellular vesicle; sEV, small extracellular vesicle; VEGF, vascular endothelial growth factor.

    Article Snippet: A375P (Research Resource Identifier [RRID]: CVCL_6233), A375-MA2 (RRID: CVCL_X495), MDA-MB-468 (RRID: CVCL_0419), 786-O (RRID: CVCL_1051), SVEC4–10 (RRID: CVCL_4393), HUVEC (RRID: CVCL_9Q53), and BJ Fibroblast (RRID: CVCL_3653) cell lines were purchased from American Type Culture Collection.

    Techniques: Incubation, Control, Inverted Microscopy, Derivative Assay

    (A, B, C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A), ROCK1, and ROCK2 are observed, corresponding to siRNA treatment compared with non-silencing control (NSC) in (A) A549, (B) H460, and (C) A375 cells (as an experimental control). Tubulin was used as a loading control. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel, percentage of invaded cells compared with NSC cells at (D) 24 h for A549, n = >4, (E) 48 h for H460, n = 6, and (F) 16 h for A375 cells, n = 3 (as an experimental control). (G, H) A549 wound healing assay. (G) Time course, percentage wound closure at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (H) Percentage wound closure at 24 h compared with wound at 0 h, n = 5. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant.

    Journal: Life Science Alliance

    Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

    doi: 10.26508/lsa.202503494

    Figure Lengend Snippet: (A, B, C) Representative Western blots in which decreased protein expression levels of Rnd3 (oligo A), ROCK1, and ROCK2 are observed, corresponding to siRNA treatment compared with non-silencing control (NSC) in (A) A549, (B) H460, and (C) A375 cells (as an experimental control). Tubulin was used as a loading control. (D, E, F) Invasion assay across a transwell membrane coated with Matrigel, percentage of invaded cells compared with NSC cells at (D) 24 h for A549, n = >4, (E) 48 h for H460, n = 6, and (F) 16 h for A375 cells, n = 3 (as an experimental control). (G, H) A549 wound healing assay. (G) Time course, percentage wound closure at each time-point compared with wound at 0 h, and data are presented as mean ± SEM. (H) Percentage wound closure at 24 h compared with wound at 0 h, n = 5. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant.

    Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

    Techniques: Western Blot, Expressing, Control, Invasion Assay, Membrane, Wound Healing Assay

    (A, B, C, D, E, F, G, H, I) Quantification of representative Western blots with samples used in cell migration and cell invasion assays in . Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (A, D, G), ROCK1 (B, E, H), and ROCK2 (C, F, I) expression after transient transfection with siRNA oligo compared with expression levels in non-silencing control cells in (A, B, C) A549, n = 5, (D, E, F) H460, n = 4, and (G, H, I) A375 cells, n = 3. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of the protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Journal: Life Science Alliance

    Article Title: Rnd3 regulates lung cancer cell invasion and migration independently of ROCK1 signaling via alpha 5 integrin modulation

    doi: 10.26508/lsa.202503494

    Figure Lengend Snippet: (A, B, C, D, E, F, G, H, I) Quantification of representative Western blots with samples used in cell migration and cell invasion assays in . Densitometric analysis was performed for each sample set over multiple biological replicates for Rnd3 (A, D, G), ROCK1 (B, E, H), and ROCK2 (C, F, I) expression after transient transfection with siRNA oligo compared with expression levels in non-silencing control cells in (A, B, C) A549, n = 5, (D, E, F) H460, n = 4, and (G, H, I) A375 cells, n = 3. Expression levels of each protein of interest were normalized to own tubulin loading control, then normalized to the expression level of the protein of interest in the NSC cells. Data are presented as an individual mean for each experiment with bar representing overall mean ± SEM. Statistical comparisons were performed using one-way ANOVA with Dunnett’s multiple test correction. ** P < 0.01, *** P < 0.001, **** P < 0.0001.

    Article Snippet: Authenticated A549 (CCL185) and H460 (HTB-177) lung adenocarcinoma cells and A375 (CRL1619) melanoma cells were obtained from the ATCC.

    Techniques: Western Blot, Migration, Expressing, Transfection, Control